Key Findings:  This study found that cannabis use is common among inflammatory bowel disease patients, particularly those with chronic symptoms or lower quality of life, with many using it for symptom relief and expressing interest in cannabinoid-based therapies, supporting the need for further clinical investigation.
Type of Study:  Meta-analysis
Study Sample Size:  291
Study Result:  Positive
Research Location(s):  Canada
Year of Pub:  2025
Cannabinoids Studied:  Cannabinoid (unspecified)
Phytocannabinoid Source:  Not Applicable
Citation:  Lal S, Prasad N, Ryan M, Tangri S, Silverberg MS, Gordon A, Steinhart H. Cannabis use amongst patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2011 Oct;23(10):891-6. doi: 10.1097/MEG.0b013e328349bb4c. PMID: 21795981.